marcus evans europe conferences

3rd Edition IDMP Compliance Challenge: Hit the phased approach deadlines

Benchmark preparations for IDMP compliance and work towards effective data management while breaking silos between divisions.

13-15 April 2016
Marriott Hotel, Frankfurt, Germany

Why You Should Attend

3rd Edition IDMP Compliance Challenge: Hit the phased approach deadlines

Identification of Medicinal Products (IDMP) is one the biggest regulatory challenges for all pharma companies in Europe. The latest regulatory update has defined IDMP compliance as a phased approach with a preparation phase between now and the end of June 2016, followed by a transition phase. The 1st iteration will be focusing on product and substance information, with further standards to come.

This marcus evans conference will focus on IDMP compliance preparations benchmarking and knowledge-sharing for the phased approach deadlines.

Despite the fact the implementation guidelines have not been published yet, decisions about the compliance preparations need to be already made today as this legislation has major implications for all companies active in the industry and this means a lot of work to be done in an a very short timeframe.

This marcus evans conference will focus on gathering corporate professionals from Regulatory Operations, Regulatory Affairs, Master Data Management, Regulatory Information Systems and other key stakeholder departments progressing on IDMP projects with already some lessons learnt and practices to share for those who are less advanced in the journey.

Join this practitioner IDMP knowledge exchange platform to discuss latest regulatory developments from EMA, FDA developments on GINAS and hear a number of case studies on IDMP projects, technology selection, post gap analysis phases, practical experiences on unstructured information and other key areas compliance requirements preparations.

Key Topics

  • Bayer Consumer Care AG adapting the IDMP project set-up to the phased approach
  • Grünenthal GmbH showcasing IDMP experiences
  • Teva presenting post gap analysis journey
  • Boehringer Ingelheim Pharma GmbH & Co. KG looking at practicalities around GINAS and substances
  • Previous Attendees Include

    Abbott Laboratories GmbH ∙ Allerghan ∙ Allergopharma GmbH & Co. KG ∙ ArisGlobal GmbH ∙ Aspen Pharma Trading Ltd ∙ Astellas ∙ Bayer Pharma AG ∙ BioMarin Pharmaceutical Inc ∙ Boehringer Ingelheim Pharma GmbH & Co ∙ Celgene Europe Limited ∙ Chiesi Farmaceutici SpA ∙ e-DRA Harmsen ∙ Ernst & Young AG ∙ F.Hoffmann-La Roche Ltd ∙ Ferring International Center SA ∙ Fresenius Kabi Deutschland GmbH ∙ Fresenius Netcare GmbH ∙ Gartner Inc ∙ Genpact Pharmalink ∙ Grunenthal GmbH ∙ Guerbet ∙ HAL Allergy ∙ HighPoint Solutions LLC ∙ i4i Inc ∙ Informatica Corporation ∙ Infotehna ∙ IT-Consulting Life Science ∙ Janssen Pharmaceutical ∙ Johnson & Johnson ∙ Kinapse ∙ LEO Pharma A/S ∙ Marr Consultancy Ltd ∙ Merck Sharp & Dohme ∙ Mesa Arch Consulting ∙ mibe GmbH Arzneimittel ∙ NNIT ∙ Norgine ∙ Novartis Pharma AG ∙ Oracle ∙ Orion Pharma ∙ PAREXEL ∙ Pfizer Incorporated ∙ Pierre Fabre Laboratories ∙ Reckitt Brnckiser Pharmaceuticals ∙ Roche ∙ Sanofi Pasteur MSD – SNC ∙ SAS Institute A/S ∙Shire International GmbH ∙ Stada Arzneimittel AG ∙ Stallergenes SA ∙ Takeda Pharma A/S ∙ Teelia EU ∙ Teva Pharmaceuticals ∙ UCB Biopharma SPRL ∙ Xendo Deutschland GbmH

    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Event Sponsors
    Visit website >>
    Visit website >>
    Visit website >>
    Visit website >>
    Visit website >>
    Visit website >>
    Visit website >>
    Visit website >>
    Visit website >>

    Event Partners

    Practical Insights From

    Dr. Andrew Marr
    Internationally recognised IDMP Compliance Expert Member, ISO Technical Commitee 215, Working Group 6
    Marr Consultancy Ltd, UK

    Kelly Hnat
    Senior Director, Regulatory Information Management

    Fiona Maini
    Director, Enterprise and Risk, Life Science Regulatory Specialist

    Jakob Juul Rasmussen
    IDMP Program Manager

    Dr. Rüdiger Faust
    Associate Director, Global Regulatory Affairs Regulatory Intelligence

    Dr. Jörg Stüben
    Senior Expert Controlled Document Management Solutions
    Boehringer Ingelheim Pharma GmbH & Co. KG

    Vladimir Sokolskyi
    Group Leader Regulatory Operations -eData Management
    MEDA Pharma GmbH & Co. KG

    Ida Bastian Jensen
    IDMP Manager
    Bayer Consumer Care AG

    Click Here For Full Agenda

    Voice of Our Customers
    • “Very fruitful conference, excellent presenters. Thank you.” IDMP Project Lead Novartis Pharma AG
    • “Great job!” Research Director Gartner
    • “Very targeted and productive event. Topic is timely and current.” VP, Life Sciences R&D Practice, HighPoint Solutions
    Latest Conference News & Resources

    Join the Discussion

    Follow on LinkedIn

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Constandinos Vinall

    marcus evans (Europe) Ltd
    PO Box 24797
    1304 Nicosia, Cyprus

    +357 22849 380
    Fax: +357 22849 394